Literature DB >> 12954219

The L-L oligomerization domain resides at the very N-terminus of the sendai virus L RNA polymerase protein.

Bayram Cevik1, Sherin Smallwood, Sue A Moyer.   

Abstract

The Sendai virus RNA-dependent RNA polymerase is composed of the L and P proteins. We previously showed that the L protein gives intragenic complementation and forms an oligomer where the L-L interaction site mapped to the N-terminal half of the protein (S. Smallwood et al., 2002, Virology, 00, 000-000). We now show that L oligomerization does not depend on P protein and progressively smaller N-terminal fragments of L from amino acids (aa) 1-1146 through aa 1-174 all bind wild-type L. C-terminal truncations up to aa 424, which bind L, can complement the transcription defect in an L mutant altered at aa 379, although these L truncation mutants do not bind P. The fragment of L comprising aa 1-895, furthermore, acts as a dominant-negative mutant to inhibit transcription of wild-type L. N-terminal deletions of aa 1-189 and aa 1-734 have lost the ability to form the L-L complex as well as the L-P complex, although they still bind C protein. These data are consistent with the L-L interaction site residing in aa 1-174. Site-directed mutations in the N-terminal 347 aa, of L which abolish P binding, do not affect L-L complex formation, so while the L and P binding sites on L are overlapping they are mediated by different amino acids. The N-terminal portions of L with aa 1-424, aa 1-381, and to a lesser extent aa 1-174, can complement the transcription defect in an L mutant altered at aa 77-81, showing their L-L interaction is functional.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12954219     DOI: 10.1016/s0042-6822(03)00342-8

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  13 in total

1.  Independent structural domains in paramyxovirus polymerase protein.

Authors:  Melanie Dochow; Stefanie A Krumm; James E Crowe; Martin L Moore; Richard K Plemper
Journal:  J Biol Chem       Date:  2012-01-03       Impact factor: 5.157

2.  A single amino acid change in the L-polymerase protein of vesicular stomatitis virus completely abolishes viral mRNA cap methylation.

Authors:  Valery Z Grdzelishvili; Sherin Smallwood; Dallas Tower; Richard L Hall; D Margaret Hunt; Sue A Moyer
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

3.  Human parainfluenza virus type 2 L protein regions required for interaction with other viral proteins and mRNA capping.

Authors:  Machiko Nishio; Masato Tsurudome; Dominique Garcin; Hiroshi Komada; Morihiro Ito; Philippe Le Mercier; Tetsuya Nosaka; Daniel Kolakofsky
Journal:  J Virol       Date:  2010-11-10       Impact factor: 5.103

4.  The L-VP35 and L-L interaction domains reside in the amino terminus of the Ebola virus L protein and are potential targets for antivirals.

Authors:  Martina Trunschke; Dominik Conrad; Sven Enterlein; Judith Olejnik; Kristina Brauburger; Elke Mühlberger
Journal:  Virology       Date:  2013-04-11       Impact factor: 3.616

5.  Analysis of a structural homology model of the 2'-O-ribose methyltransferase domain within the vesicular stomatitis virus L protein.

Authors:  Summer E Galloway; Paul E Richardson; Gail W Wertz
Journal:  Virology       Date:  2008-10-11       Impact factor: 3.616

6.  Phosphoprotein, P of human parainfluenza virus type 3 prevents self-association of RNA-dependent RNA polymerase, L.

Authors:  Santanu Chattopadhyay; Amiya K Banerjee
Journal:  Virology       Date:  2008-11-13       Impact factor: 3.616

7.  Structure-guided design of small-molecule therapeutics against RSV disease.

Authors:  Robert Cox; Richard K Plemper
Journal:  Expert Opin Drug Discov       Date:  2016-04-21       Impact factor: 6.098

8.  Evidence for phosphorylation of human parainfluenza virus type 3 C protein: mutant C proteins exhibit variable inhibitory activities in vitro.

Authors:  Achut G Malur; Greg Wells; Almedia McCoy; Amiya K Banerjee
Journal:  Virus Res       Date:  2009-05-04       Impact factor: 3.303

Review 9.  The paramyxovirus polymerase complex as a target for next-generation anti-paramyxovirus therapeutics.

Authors:  Robert Cox; Richard K Plemper
Journal:  Front Microbiol       Date:  2015-05-12       Impact factor: 5.640

10.  Genetic trans-complementation establishes a new model for influenza virus RNA transcription and replication.

Authors:  Núria Jorba; Rocío Coloma; Juan Ortín
Journal:  PLoS Pathog       Date:  2009-05-29       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.